WallStreet_Tiger

Care what investors cares

    • WallStreet_TigerWallStreet_Tiger
      ·16:12

      Q3| US Earnings Reality Check

      🐯 Profits Up, Stocks Down? TSLA, NFLX and JPM Face Their Next Test As of October 27, 2026 | Recent releases from October 13–21 | All outlooks below are editorial scenarios Hey Tigers! 🐯 Earnings season is giving investors plenty of numbers to digest. But the question for your portfolio is what those numbers mean for the next quarter — and how much optimism the stock already prices in. Tesla’s cash flow recovered sequentially while profit remained under pressure. Netflix delivered stronger margins but a slower growth outlook. JPMorgan showed broad business strength alongside credit costs and a more cautious approach to share repurchases. [1–3] My take: earnings quality and the next earnings revision deserve more weight than the headline growth rate. Here are three widely followed names wort
      7346
      Report
      Q3| US Earnings Reality Check
    • WallStreet_TigerWallStreet_Tiger
      ·15:23

      Wall Street Analyst Upgrades & Downgrades: October 19–23, 2026

      Which U.S. stocks are Wall Street analysts becoming more bullish or bearish on? Last week’s analyst rating changes highlighted diverging views across AI software, semiconductors, technology hardware, financial services, and consumer-facing businesses. Investors should distinguish between three types of changes: Rating Upgrade: An analyst raises a stock's rating, such as from Hold to Buy. Rating Downgrade: An analyst lowers a rating, such as from Buy to Hold. Price Target Revision: An analyst changes the expected price level without necessarily changing the stock rating. Below are selected examples of reported analyst actions during the week. 1. Stocks Receiving Analyst Upgrades Ticker Brokerage Rating Change Latest Price Target $Datadog(DDOG)$ Ber
      6.56K12
      Report
      Wall Street Analyst Upgrades & Downgrades: October 19–23, 2026
    • WallStreet_TigerWallStreet_Tiger
      ·10-23

      Nasdaq Drops 2.6% as AI Fears Return: 3 Inverse ETFs to Know

      The AI trade hit a fresh test on October 22. The Nasdaq Composite plunged 2.6% to 26,008.86, its steepest daily percentage decline since June, as investors reconsidered the cost of the AI boom. The S&P 500 fell 1.21%, while the Philadelphia Semiconductor Index sank 6.7%. The pressure was especially visible in companies tied to the AI investment race. $Meta Platforms, Inc.(META)$ dropped around 7% even after reporting quarterly revenue above expectations, as investors focused on its mounting AI-related spending and plans to raise capital. The bigger question is whether heavy AI investment will generate returns quickly enough to justify the bill. For traders expecting further weakness, inverse ETFs offer a way to take bearish exp
      8.74K7
      Report
      Nasdaq Drops 2.6% as AI Fears Return: 3 Inverse ETFs to Know
    • WallStreet_TigerWallStreet_Tiger
      ·10-20

      🐯 💰 Nvidia GTC Berlin: Can AI Chips and Memory Stocks Extend Their Rebound?

      Semiconductor stocks are recovering from a sharp selloff, while $NVIDIA(NVDA)$ 's upcoming keynote and Micron's record earnings put the AI supply chain back in focus. Hey Tigers! 🐯 After eight consecutive sessions of losses, semiconductor stocks finally rebounded on October 19. The Philadelphia Semiconductor Index (SOX) gained 1.6%, snapping a losing streak that had wiped approximately 15.7% off the index. The recovery comes just as Nvidia's GTC Berlin 2026 gets underway, with CEO Jensen Huang's keynote scheduled for October 21. Meanwhile, Micron's record earnings and strong demand for AI memory chips are providing further evidence of growth across the semiconductor supply chain. Can upcoming AI announcements and earnings turn this rebound into a
      7.70K33
      Report
      🐯 💰 Nvidia GTC Berlin: Can AI Chips and Memory Stocks Extend Their Rebound?
    • WallStreet_TigerWallStreet_Tiger
      ·10-20

      Morgan Stanley Turns Bullish on 8 Biotech Stocks: PTCT and BLTE Lead With Billion-Dollar Drug Opport

      Morgan Stanley has initiated coverage on eight biotechnology companies spanning rare diseases, eye disorders, lung diseases and mental health. The firm sees significant potential in $PTC Therapeutics(PTCT)$ and $Belite Bio, Inc.(BLTE)$ , while $Trevi Therapeutics, Inc.(TRVI)$ and $COMPASS Pathways plc(CMPS)$ offer additional opportunities tied to clinical progress and potential commercialization. The common thread? Each company is developing treatments for conditions where existing options remain limited — creating potentially attractive markets, but also si
      8.77K8
      Report
      Morgan Stanley Turns Bullish on 8 Biotech Stocks: PTCT and BLTE Lead With Billion-Dollar Drug Opport
    • WallStreet_TigerWallStreet_Tiger
      ·10-19

      🐯 Wall Street’s Upgrade & Downgrade Radar: The Biggest Analyst Calls of the Week

      Hey Tigers! 🐯 Another week, another round of Wall Street analysts reassessing their favorite stocks. From AI software and semiconductor infrastructure to consumer brands and media companies, analysts sent mixed signals about where they see the biggest opportunities — and risks. Some companies received significant upgrades and higher price targets, while others faced growing concerns about valuations and future growth. Let's break down some of the week's most notable analyst calls from October 12–16, 2026! 👇 📅 Monday, Oct. 12: Salesforce Gets a Major AI-Era Upgrade 🤖 Stock Firm Rating Change Price Target 🟢 $Salesforce.com(CRM)$ $Bank of America(BAC)$ Underperform → Buy $285 🔴
      7.36K7
      Report
      🐯 Wall Street’s Upgrade & Downgrade Radar: The Biggest Analyst Calls of the Week
    • WallStreet_TigerWallStreet_Tiger
      ·10-15

      🚗 Tesla’s October Double Test: Roadster Reveal Oct. 15, Earnings Oct. 21 — Can TSLA Rebound?

      A long-awaited product event, chipmaking discussions and an energy milestone put Tesla in focus ahead of its October 21 earnings report. Hey Tigers 🐯 — Tesla is heading into another closely watched product event, but its stock is arriving under pressure. $特斯拉(TSLA)$ closed October 14 at $367.16, down 2.15%, ahead of its delayed Roadster presentation. The stock has fallen 2.82% over five trading days, despite retaining a 2.28% gain over the past month. The broader picture remains challenging, with shares down 7.32% over three months and 18.36% year to date. That puts the Roadster reveal in focus as investors look for concrete progress to support a recovery.Meanwhile, $台积电(TSM)$</
      3.30K10
      Report
      🚗 Tesla’s October Double Test: Roadster Reveal Oct. 15, Earnings Oct. 21 — Can TSLA Rebound?
    • WallStreet_TigerWallStreet_Tiger
      ·10-14

      What the Tigers say:JPM, GS, WFC, C Kick Off Q3 — and Wall Street Picks Its Metric

      Hi Tigers 🐯, Welcome to "What the Tigers say." 👋 Big-bank earnings season kicks off on October 13 with $JPMorgan Chase(JPM)$ $Goldman Sachs(GS)$ $Wells Fargo(WFC)$ and $Citigroup(C)$ reporting third-quarter results, and the community spent the run-up debating what actually holds bank valuations up: headline profits, net interest margins, or tangible book value. With rates volatile and $Berkshire Hathaway(BRK.B)$ still trimming $Bank of America(BAC)$
      4.37K7
      Report
      What the Tigers say:JPM, GS, WFC, C Kick Off Q3 — and Wall Street Picks Its Metric
    • WallStreet_TigerWallStreet_Tiger
      ·10-13

      🐂 The Bull Market Turns Four: Can Q3 Earnings Power the Next Leg Higher?

      From AI-driven gains to earnings reality, here's what investors should watch as Wall Street heads into Q4. Four years. A remarkable rally. And a new test for Wall Street. The S&P 500's current bull market reached its fourth anniversary on October 12, 2026, having climbed approximately 118% from its October 2022 low. AI investment, resilient corporate earnings and enthusiasm for technology have helped fuel the advance. But the next phase may be more challenging. Rising bond yields, questions about AI profitability and uneven stock performance are forcing investors to look beyond headline index gains. Now, Q3 earnings season is stepping into the spotlight. 🏦 The key question: Can corporate earnings justify the rally and carry the market into Q4? 📊 1. Four Years Into the Rally: Where Is t
      2.10K10
      Report
      🐂 The Bull Market Turns Four: Can Q3 Earnings Power the Next Leg Higher?
    • WallStreet_TigerWallStreet_Tiger
      ·10-12

      📈📉 MSFT, MRVL & PLTR Upgraded — What Is Wall Street Repricing?

      Wall Street reshuffled its calls last week, with analysts changing their views across AI, software, semiconductors, healthcare and consumer stocks. From $Microsoft(MSFT)$getting a bullish AI-security call to $Nike(NKE)$ facing deeper turnaround concerns, here are the key institutional moves from October 5–9 — and more importantly, why analysts changed their minds. 📅 MONDAY, OCT 5 | AI Security Becomes a New Bull Case 🟢 $Microsoft(MSFT)$Melius Research: Hold → Buy | PT: $465 → $665 Melius upgraded $Microsoft(MSFT)$, arguing that growing concerns around AI secu
      2.44K12
      Report
      📈📉 MSFT, MRVL & PLTR Upgraded — What Is Wall Street Repricing?
       
       
       
       

      Most Discussed